| Free Is Meta's Growth Already Priced In? Six straight beats ended with an EPS miss — the question is no longer whether Meta can grow, but how much is incremental. By KAPUALabs / 18 Aug 2026
| Free Meta's AI Bet: Moat or Capital Sink? Vertical integration offers resilience, but rising rack densities, power bottlenecks, and overbuild risk cloud the returns outlook. By KAPUALabs / 18 Aug 2026
| Free Can Meta Monetize AI Without Breaking the Machine? Advertising funds the compute, open weights commoditize the models, and the governance board remains untested across an expanding AI footprint. By KAPUALabs / 18 Aug 2026
| Free Inside the Soft-Landing Repricing How cooling payrolls, easing inflation, and shifting Fed expectations are rewriting valuations for long-duration growth stocks By KAPUALabs / 18 Aug 2026
| Free AI Governance Becomes Operating Infrastructure for Meta A definitive review of binding EU obligations, voluntary standards, and Meta's emerging board-level oversight architecture through 2026–2028. By KAPUALabs / 18 Aug 2026
| Free The Bull Case Fades Into a Mix Question Impressions up 14% and clicks up 8.3%, yet Asia-Pacific price growth near 1% shows where Meta's volume turns profitable. By KAPUALabs / 18 Aug 2026
| Free Meta's Advertising Moat: A Definitive Assessment An evidence-based examination of growth durability, measurement integrity, and the structural risks beneath Meta's platform business By KAPUALabs / 18 Aug 2026
| Free The Bull Case Hinges on Cash. The Bear Case Has Math. Meta's 37x FCF multiple and 0.3% dividend yield frame a high-stakes debate over whether AI spending can restore shareholder distributions. By KAPUALabs / 18 Aug 2026
| Free Meta's Margin Question: Compliance Drag or Competitive Moat? A two-scenario look at how mandatory age assurance, AI governance, and wearable privacy rules may reshape Meta's earnings trajectory By KAPUALabs / 18 Aug 2026
| Free Anatomy of Eli Lilly’s GLP-1 Obesity Franchise Domination A comprehensive evaluation of tirzepatide revenue drivers, manufacturing scale, and the commercial outlook for oral treatments. By KAPUALabs / 18 Aug 2026
| Free How Do You Prove a Digital Platform Actually Works? Attribution collapse, programmatic shifts, and rising scrutiny on conversion data force Meta and peers to defend every dollar of advertising revenue. By KAPUALabs / 18 Aug 2026
| Free Meta's AI Bull Case Hides a Section 230 Liability Exceptional distribution and AI capability are offset by rising litigation, fragmented compliance, and the collapse of early-dismissal defenses By KAPUALabs / 18 Aug 2026